Skip to main content

Advertisement

SpringerLink
Log in

Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Previous studies have revealed that genetic polymorphisms of the Glutathione S-transferase M1 and T1 (GSTM1 and GSTT1), tumor necrosis factor-α (TNF-α), and interleukin 6 (IL-6) are associated with the presence of non-alcoholic fatty liver disease (NAFLD) in many populations. This study was conducted to investigate the association of the GSTM1, GSTT1, TNF-α rs1800629, and IL-6 rs1800795 with NAFLD in the general Iranian population. A case-control analysis included 242 NAFLD patients and 324 healthy controls from Iranian adults. After the physical examination, the genotypes were determined by polymerase chain reaction(PCR). The GSTM1 null, GSTT1 null, TNF-α AG/AA, and IL-6 CG/CC genotypes were deemed to be high-risk. The null allele of GSTM1 and A allele of TNF-α were more frequent in NAFLD patients even after Bonferroni’s correction (P values<0.005, adjusted odds ratio (OR), 1.66 and 2.02; 95% confidence intervals (CI), (1.18–2.32) and (1.34–3.34), respectively. The IL-6 CC/CG genotype association with NAFLD was not significant after correction (P value = 0.04) Polymorphisms of xenobiotic and pro-inflammatory genes are associated with NAFLD in the Iranian population and seem to be a useful tool for NAFLD prevention and care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346(16):1221–1231. https://doi.org/10.1056/nejmra011775

    Article  CAS  PubMed  Google Scholar 

  2. Moghaddasifar I, Lankarani K, Moosazadeh M, Afshari M, Ghaemi A, Aliramezany M, Gharebagh RA, Malary M (2016) Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int J Organ Trans Med 7(3):149. https://doi.org/10.5812/modernc.58829

    Article  CAS  Google Scholar 

  3. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341–1350. https://doi.org/10.1056/nejmra0912063

    Article  CAS  PubMed  Google Scholar 

  4. Yu Y, Cai J, She Z, Li H (2019) Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases. Adv Sci 6(4):1801585. https://doi.org/10.1002/advs.201801585

    Article  CAS  Google Scholar 

  5. Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH (2009) Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 51(2):371–379. https://doi.org/10.1016/j.jhep.2009.03.019

    Article  CAS  PubMed  Google Scholar 

  6. Kanth VVR, Sasikala M, Sharma M, Rao PN, Reddy DN (2016) Genetics of non-alcoholic fatty liver disease: from susceptibility and nutrient interactions to management. World J Hepatol 8(20):827. https://doi.org/10.4254/wjh.v8.i20.827

    Article  Google Scholar 

  7. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88. https://doi.org/10.1146/annurev.pharmtox.45.120403.095857

    Article  CAS  PubMed  Google Scholar 

  8. Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61(3):154–166. https://doi.org/10.1159/000028396

    Article  CAS  PubMed  Google Scholar 

  9. Vats P, Kushwah AS, Banerjee M (2017) Association of antioxidant gene variants with type 2 diabetes mellitus in different ethnic groups. Eur J Biomed Pharm Sci 4:290–298

    CAS  Google Scholar 

  10. Hussain T, Alrokayan S, Upasna U, Pavithrakumari M, Jayapriya J, Kutala VK, Naushad SM (2018) Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk. J Genet 97(2):523–537. https://doi.org/10.1007/s12041-018-0946-4

    Article  CAS  PubMed  Google Scholar 

  11. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, Zhang D, Zhou W (2010) Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol 53(3):508–518. https://doi.org/10.1016/j.jhep.2010.03.026

    Article  CAS  PubMed  Google Scholar 

  12. Hori M, Oniki K, Nakagawa T, Takata K, Mihara S, Marubayashi T, Nakagawa K (2009) Association between combinations of glutathione-S-transferase M1, T1 and P1 genotypes and non-alcoholic fatty liver disease. Liver Int 29(2):164–168. https://doi.org/10.1111/j.1478-3231.2008.01794.x

    Article  CAS  PubMed  Google Scholar 

  13. Baclig MO, Alvarez MR, Lozada XMR, Mapua CA, Lozano-Kühne JP, Dimamay MPS, Natividad FF, Gopez-Cervantes J, Matias RR (2012) Association of glutathione S-transferase T1 and M1 genotypes with chronic liver diseases among Filipinos. Int J Mol Epidemiol Genetics 3(2):153

    CAS  Google Scholar 

  14. Oniki K, Hori M, Saruwatari J, Morita K, Kajiwara A, Sakata M, Mihara S, Ogata Y, Nakagawa K (2013) Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. Toxicol Lett 220(2):143–149. https://doi.org/10.1016/j.toxlet.2013.04.019

    Article  CAS  PubMed  Google Scholar 

  15. Miele L, Dall’Armi V, Cefalo C, Nedovic B, Arzani D, Amore R, Rapaccini G, Gasbarrini A, Ricciardi W, Grieco A (2014) A case–control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. Genes Nutr 9(2):383. https://doi.org/10.1007/s12263-013-0383-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hashemi M, Eskandari-Nasab E, Fazaeli A, Bahari A, Hashemzehi N-A, Shafieipour S, Taheri M, Moazeni-Roodi A, Zakeri Z, Bakhshipour A (2012) Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan, Southeast Iran. DNA Cell Biol 31(5):672–677. https://doi.org/10.1089/dna.2011.1343

    Article  CAS  PubMed  Google Scholar 

  17. Shamansurova ZM, Saatov TS, Takhirov LS (2020) Tumor necrosis factor alpha: role in the development of obesity and diabetes mellitus. Asian J Biochem Genetics Mol Biol, pp 29–42. https://doi.org/10.9734/ajbgmb/2020/v4i330108

  18. Kroeger KM, Carville KS, Abraham LJ (1997) The− 308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 34(5):391–399. https://doi.org/10.1016/s0161-5890(97)00052-7

    Article  CAS  PubMed  Google Scholar 

  19. Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, Distler A, Sharma A (2001) Tumor necrosis factor-α− 308 G/A polymorphism in obese Caucasians. Int J Obes 25(4):581–585. https://doi.org/10.1038/sj.ijo.0801576

    Article  CAS  Google Scholar 

  20. Zhang H-F, Xie S-L, Wang J-F, Chen Y-X, Wang Y, Huang T-C (2011) Tumor necrosis factor-alpha G-308A gene polymorphism and coronary heart disease susceptibility: an updated meta-analysis. Thromb Res 127(5):400–405. https://doi.org/10.1016/j.thromres.2010.12.018

    Article  CAS  PubMed  Google Scholar 

  21. Kurbatova I, Topchieva L, Dudanova O (2017) Gene TNF polymorphism-308g> a (rs1800629) and its relationship with the efficiency of ursodeoxycholic acid therapy in patients with nonalcoholic stetohepatitis. Bull Exp Biol Med 164(2):181–185. https://doi.org/10.1007/s10517-017-3953-1

    Article  CAS  PubMed  Google Scholar 

  22. Stojsavljević S, Palčić MG, Jukić LV, Duvnjak LS, Duvnjak M (2014) Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol: WJG 20(48):18070. https://doi.org/10.3748/wjg.v20.i48.18070

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE (2008) Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 103(6):1372–1379. https://doi.org/10.1111/j.1572-0241.2007.01774.x

    Article  CAS  PubMed  Google Scholar 

  24. Chunmin Z, Cheng Z (2019) IL-6 gene rs1800795 polymorphism and diabetes mellitus: a comprehensive analysis involving 39099 participants. https://doi.org/10.21203/rs.2.16985/v1

  25. Wang LI, Giovannucci EL, Hunter D, Neuberg D, Su L, Christiani DC (2004) Dietary intake of cruciferous vegetables, glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control 15(10):977–985. https://doi.org/10.1007/s10552-004-1093-1

    Article  PubMed  Google Scholar 

  26. Moghadam AM, Saedisomeolia A, Djalali M, Djazayery A, Pooya S, Sojoudi F (2012) Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients. Singapore Med J 53(9):615–619. https://doi.org/10.11622/smedj.2013013

    Article  Google Scholar 

  27. Belisle SE, Leka LS, Dallal GE, Jacques PF, Ordovas JM, Meydani SN, Delgado-Lista J (2008) Cytokine response to vitamin E supplementation is dependent on pre-supplementation cytokine levels. Biofactors 33(3):191–200. https://doi.org/10.1002/biof.5520330305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American. Gastroenterol Assoc Hepatol 55(6):2005–2023. https://doi.org/10.1002/hep.25762

    Article  Google Scholar 

  29. Musso G, Gambino R, Cassader M (2011) Need for a three-focused approach to nonalcoholic fatty liver disease. Hepatology 53(5):1773–1773. https://doi.org/10.1002/hep.24070

    Article  PubMed  Google Scholar 

  30. Barrera F, George J (2014) The role of diet and nutritional intervention for the management of patients with NAFLD. Clin Liver Dis 18(1):91–112. https://doi.org/10.1016/j.cld.2013.09.009

    Article  PubMed  Google Scholar 

  31. Kang JX (2012) The coming of age of nutrigenetics and nutrigenomics. Lifestyle Genomics 5(1):I–II. https://doi.org/10.1159/000339375

    Article  Google Scholar 

  32. Alidoost S, Habibi M, Noormohammadi Z, Hosseini J, Azargashb E, Pouresmaeili F (2020) Association between tumor necrosis factor-alpha gene rs1800629 (−308G/a) and rs361525 (−238G> a) polymorphisms and prostate cancer risk in an Iranian cohort. Human Antibodies (Preprint):1–10. https://doi.org/10.3233/hab-190397

  33. Abbasabad GD, Khojasteh SMB, Naji HE, Zamani MR, Hajipour H, Serati-Nouri H (2018) An interleukin-6 single nucleotide polymorphism and susceptibility to prostate adenocarcinoma and bone metastasis in an iranian population. Asian Pacific J cancer Prevention: APJCP 19(6):1717

    CAS  Google Scholar 

  34. Allocati N, Masulli M, Di Ilio C, Federici L (2018) Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis 7(1):1–15. https://doi.org/10.1038/s41389-017-0025-

    Article  CAS  Google Scholar 

  35. Huang Y-S, Su W-J, Huang Y-H, Chen C-Y, Chang F-Y, Lin H-C, Lee S-D (2007) Genetic polymorphisms of manganese superoxide dismutase, NAD (P) H: quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol 47(1):128–134. https://doi.org/10.1016/j.jhep.2007.02.009

    Article  CAS  PubMed  Google Scholar 

  36. Ghobadloo SM, Yaghmaei B, Bakayev V, Goudarzi H, Noorinayer B, Rad FH, Samiy S, Aghabozorghi S, Zali MR (2004) GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis. J Gastrointest Surg 8(4):423–427. https://doi.org/10.1016/s0168-8278(03)80617-7

    Article  PubMed  Google Scholar 

  37. Bolt H, Thier R (2006) Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 7(6):613–628

    Article  CAS  PubMed  Google Scholar 

  38. Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, Baranova A, Younossi Z (2010) Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. Obes Surg 20(5):640–650. https://doi.org/10.2174/138920006778017786

    Article  PubMed  Google Scholar 

  39. Navarro SL, Chang J-L, Peterson S, Chen C, King IB, Schwarz Y, Li SS, Li L, Potter JD, Lampe JW (2009) Modulation of human serum glutathione S-transferase A1/2 concentration by cruciferous vegetables in a controlled feeding study is influenced by GSTM1 and GSTT1 genotypes. Cancer Epidemiol Prevention Biomarkers 18(11):2974–2978. https://doi.org/10.1158/1055-9965.epi-09-0701

    Article  CAS  Google Scholar 

  40. Caporaso N, Morisco F, Camera S, Graziani G, Donnarumma L, Ritieni A (2012) Dietary approach in the prevention and treatment of NAFLD. Front Biosci (Landmark edition) 17:2259–2268. https://doi.org/10.2741/4049

    Article  CAS  Google Scholar 

  41. Tilg H (2010) The role of cytokines in non-alcoholic fatty liver disease. Dig Dis 28(1):179–185. https://doi.org/10.1159/000282083

    Article  CAS  PubMed  Google Scholar 

  42. Ebersole JL, Graves CL, Gonzalez OA, Dawson D III, Morford LA, Huja PE, Hartsfield JK Jr, Huja SS, Pandruvada S, Wallet SM (2016) Aging, inflammation, immunity and periodontal disease. Periodontology 72(1):54–75. https://doi.org/10.1111/prd.12135

    Article  Google Scholar 

  43. Kruger FC, Pretorius J, Daniels C, Van Der Merwe L, Kotze MJ (2013) Mo1051 TNF-α Rs1800629 (− 308 G> a) genotyping may identify obese individuals at high risk for development of non-alcoholic fatty liver disease (NAFLD). Gastroenterology 144(5):S-1022. https://doi.org/10.1016/s0016-5085(13)63797-x

    Article  Google Scholar 

  44. Qidwai T, Khan F (2011) Tumour necrosis factor gene polymorphism and disease prevalence. Scand J Immunol 74(6):522–547. https://doi.org/10.1111/j.1365-3083.2011.02602.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB, Pahor M, Taaffe DR, Brach J, Rubin S (2004) Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study. J Am Geriatr Soc 52(7):1098–1104. https://doi.org/10.1111/j.1532-5415.2004.52307.x

    Article  PubMed  Google Scholar 

  46. Wang X, Yan Z, Ye Q (2019) Interleukin-6 gene polymorphisms and susceptibility to liver diseases: a meta-analysis. Medicine 98(50). https://doi.org/10.1097/md.0000000000018408

  47. Bhatt SP, Guleria R, Vikram NK, Nandhan S, Singh Y, Gupta A (2018) Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in North India. PLoS One 13(7):e0199599. https://doi.org/10.1371/journal.pone.0199599

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Nelson JE, Handa P, Aouizerat B, Wilson L, Vemulakonda LA, Yeh MM, Kowdley KV, Network NCR, Abrams SH, Himes R (2016) Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL 1B and IL 6 polymorphisms. Aliment Pharmacol Ther 44(11–12):1253–1264. https://doi.org/10.1111/apt.13824

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Carulli L, Canedi I, Rondinella S, Lombardini S, Ganazzi D, Fargion S, De Palma M, Lonardo A, Ricchi M, Bertolotti M (2009) Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6− 174G/C polymorphism is associated with non-alcoholic steatohepatitis. Dig Liver Dis 41(11):823–828. https://doi.org/10.1016/j.dld.2009.03.005

    Article  CAS  PubMed  Google Scholar 

  50. Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44(6):1167–1174. https://doi.org/10.1016/j.jhep.2006.02.011

    Article  CAS  PubMed  Google Scholar 

  51. Macaluso FS, Maida M, Petta S (2015) Genetic background in nonalcoholic fatty liver disease: a comprehensive review. World J Gastroenterol: WJG 21(39):11088. https://doi.org/10.3748/wjg.v21.i39.11088

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Hollman AL, Tchounwou PB, Huang H-C (2016) The association between gene-environment interactions and diseases involving the human GST superfamily with SNP variants. Int J Environ Res Public Health 13(4):379. https://doi.org/10.3390/ijerph13040379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Seo YY, Cho YK, Bae J-C, Seo MH, Park SE, Rhee E-J, Park C-Y, Oh K-W, Park S-W, Lee W-Y (2013) Tumor necrosis factor-α as a predictor for the development of nonalcoholic fatty liver disease: a 4-year follow-up study. Endocrinol Metab 28(1):41–45. https://doi.org/10.3803/enm.2013.28.1.41

    Article  Google Scholar 

  54. Asrih M, Jornayvaz FR (2013) Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 218(3):R25–R36. https://doi.org/10.1530/joe-13-0201

    Article  CAS  PubMed  Google Scholar 

  55. Yu J, Marsh S, Hu J, Feng W, Wu C (2016, 2016) The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background. Gastroenterol Res Pract. https://doi.org/10.1155/2016/2862173

  56. Nasef NA, Mehta S, Ferguson LR (2017) Susceptibility to chronic inflammation: an update. Arch Toxicol 91(3):1131–1141. https://doi.org/10.1007/s00204-016-1914-5

    Article  CAS  PubMed  Google Scholar 

  57. Wandrer F, Liebig S, Marhenke S, Vogel A, John K, Manns MP, Teufel A, Itzel T, Longerich T, Maier O (2020) TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death Dis 11(3):1–9. https://doi.org/10.1038/s41419-020-2411-6

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all the staff of Dr. Zeinali’s Medical Genetics Laboratory.

Author information

Authors and Affiliations

  1. Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran

    Narges Damavandi & Sirous Zeinali

  2. Dr. Zeinali’s Medical Genetics Laboratory, Kawsar Human Genetics Research Center, Tehran, Iran

    Narges Damavandi & Sirous Zeinali

  3. Department of Molecular Medicine, Pasteur Institute of Iran, Biotechnology Research Center, Tehran, Iran

    Sirous Zeinali

Authors
  1. Narges Damavandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sirous Zeinali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sirous Zeinali.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Damavandi, N., Zeinali, S. Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease. Mol Biol Rep 48, 1225–1231 (2021). https://doi.org/10.1007/s11033-021-06142-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-021-06142-1

Keywords

Search

Navigation